EFFECT OF MACITENTAN ON PULMONARY ARTERIAL HYPERTENSION-RELATED HOSPITALISATIONS: RESULTS FROM THE RANDOMISED CONTROLLED SERAPHIN TRIAL

被引：0
|
作者：
Coghlan, G. [1 ]
Channick, R. N. [2 ]
Rubin, L. J. [3 ]
Galie, N. [4 ]
Perchenet, L. [5 ]
Simonneau, G. [6 ]
机构：
[1] Royal Free Hosp, London NW3 2QG, England
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Univ Calif San Diego, San Diego, CA 92103 USA
[4] Univ Bologna, Bologna, Italy
[5] Actel Pharmaceut Ltd, Allschwil, Switzerland
[6] Hop Univ Bicetre, Le Kremlin Bicetre, France
来源：
THORAX | 2013年 / 68卷
关键词：
D O I：
10.1136/thoraxjnl-2013-204457.299
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：A143 / A143
页数：1
相关论文
共 50 条
  • [1] Effect of macitentan on morbidity and mortality in pulmonary arterial hypertension: A randomised controlled trial (SERAPHIN)
    Ghofrani, Hossein-Ardeschir
    Channick, Richard
    Delcroix, Marion
    Galie, Nazzareno
    Jansa, Pavel
    Le Brun, Franck-Olivier
    Mehta, Sanjay
    Mittelholzer, Camilla
    Pulido, Tomas
    Sastry, B. K. S.
    Sitbon, Olivier
    Souza, Rogerio
    Torbicki, Adam
    Rubin, Lewis
    Simonneau, Gerald
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [2] Effect of macitentan on haemodynamics in SERAPHIN, a randomised controlled trial in pulmonary arterial hypertension (PAH)
    Sitbon, Olivier
    Channick, Richard
    Delcroix, Marion
    Galie, Nazzareno
    Ghofrani, Hossein-Ardeschir
    Jansa, Pavel
    Le Brun, Franck-Olivier
    Mehta, Sanjay
    Perchenet, Loic
    Pulido, Tomas
    Sastry, B. K. S.
    Souza, Rogerio
    Torbicki, Adam
    Rubin, Lewis
    Simonneau, Gerald
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [3] EFFECT OF MACITENTAN ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PULMONARY ARTERIAL HYPERTENSION (PAH): RESULTS FROM THE SERAPHIN RANDOMISED CONTROLLED TRIAL
    Youssef, P.
    Galie, N.
    Perchenet, L.
    Rubin, L.
    Simonneau, G.
    Mehta, S.
    [J]. INTERNAL MEDICINE JOURNAL, 2014, 44 : 31 - 31
  • [4] EFFECT OF MACITENTAN ON HAEMODYNAMICS IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM THE LONG-TERM, RANDOMISED, PLACEBO-CONTROLLED SERAPHIN TRIAL
    Coghlan, G.
    Torbicki, A.
    Galie, N.
    Rubin, L. J.
    Perchenet, L.
    Simonneau, G.
    [J]. THORAX, 2013, 68 : A26 - A26
  • [5] Effect of macitentan on haemodynamics in patients with pulmonary arterial hypertension: results from the long-term, randomised, placebo-controlled SERAPHIN trial
    Torbicki, A.
    Mehta, S.
    Perchenet, L.
    Pulido, T.
    Sastry, B. K. S.
    Sitbon, O.
    Souza, R.
    Rubin, L. J.
    Simonneau, G.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 186 - 186
  • [6] REDUCTION OF PULMONARY ARTERIAL HYPERTENSION (PAH)-RELATED HOSPITALIZATIONS WITH MACITENTAN IN THE RANDOMIZED CONTROLLED TRIAL SERAPHIN
    Channick, R. N.
    Delcroix, M.
    Galie, N.
    Ghofrani, H. A.
    Hunsche, E.
    Jansa, P.
    Le Brun, F. O.
    Mehta, S.
    Mittelholzer, C.
    Perchenet, L.
    Pulido, T.
    Sastry, B.
    Sitbon, O.
    Souza, R.
    Torbicki, A.
    Rubin, L. J.
    Simonneau, G.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A231 - A231
  • [7] Macitentan Improves Health-Related Quality Of Life In Pulmonary Arterial Hypertension: Results From The Randomized Controlled Seraphin Trial
    Mehta, S.
    Channick, R. N.
    Delcroix, M.
    Galie, N.
    Ghofrani, H. -A.
    Hunsche, E.
    Jansa, P.
    Le Brun, F. -O.
    Mittelholzer, C.
    Perchenet, L.
    Pulido, T.
    Souza, R.
    Sastry, B.
    Torbicki, A.
    Sitbon, O.
    Rubin, L. J.
    Simonneau, G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [8] Macitentan in Pulmonary Arterial Hypertension: A Focus on Combination Therapy in the SERAPHIN Trial
    Jansa, Pavel
    Pulido, Tomas
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2018, 18 (01) : 1 - 11
  • [9] Macitentan in Pulmonary Arterial Hypertension: A Focus on Combination Therapy in the SERAPHIN Trial
    Pavel Jansa
    Tomás Pulido
    [J]. American Journal of Cardiovascular Drugs, 2018, 18 : 1 - 11
  • [10] Anticoagulant therapy does not influence long-term outcomes in patients with pulmonary arterial hypertension (PAH): insights from the randomised controlled SERAPHIN trial of macitentan
    Galie, N.
    Delcroix, M.
    Ghofrani, H. -A.
    Jansa, P.
    Minai, O. A.
    Perchenet, L.
    Rubin, L. J.
    Sastry, B. K. S.
    Torbicki, A.
    Simonneau, G.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 10 - 10
12345